- Home
- OMAB vs INDV Comparison
OMAB vs INDV Comparison
Compare OMAB & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OMAB | INDV |
|---|---|---|
| Founded | 1998 | N/A |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.7B |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OMAB | INDV |
|---|---|---|
| Price | $102.33 | $36.90 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $120.00 | N/A |
| AVG Volume (30 Days) | 45.8K | ★ 2.4M |
| Earning Date | 04-28-2026 | 06-08-2026 |
| Dividend Yield | ★ 4.06% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.67 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $8.36 | N/A |
| Revenue Next Year | $13.05 | N/A |
| P/E Ratio | ★ $21.86 | $22.62 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $95.69 | $22.22 |
| 52 Week High | $134.99 | $42.81 |
Technical Indicators
Market Signals| Indicator | OMAB | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 37.17 |
| Support Level | $96.86 | $35.49 |
| Resistance Level | $104.16 | $38.08 |
| Average True Range (ATR) | 2.82 | 1.41 |
| MACD | -0.74 | -0.13 |
| Stochastic Oscillator | 22.14 | 26.18 |
Price Performance
Historical ComparisonAbout OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
Grupo Aeroportuario del Centro Norte SAB de CV operates, maintains and develops airports in the Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages hotels, industrial parks, and individual airports. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, and in Others.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).